Adragos Hub

In the complex and highly regulated world of pharmaceuticals, ensuring the safe and efficient distribution of medications is paramount. This article delves into the crucial role of secondary packaging in enhancing supply chain resilience. From defining secondary packaging and distinguishing […]

The rapidly evolving landscape of disease understanding and therapeutic technologies is reshaping the pharmaceutical sector. As a global Contract Development and Manufacturing Organization (CDMO), we are at the forefront of these advancements, providing both burgeoning and seasoned pharmaceutical companies with […]

Biosimilars represent a dynamic frontier in the biopharmaceutical sector, mirroring the complexities and promising potentials of their reference biologics—innovative biological medicines made from living cells. Unlike standard generics, biosimilars are not exact copies but are highly similar to an original […]

Clinical trials are fundamental to the advancement of medical science and patient care, providing critical data that supports the development of new treatments and therapies. This comprehensive guide explores various aspects of clinical trials, offering valuable insights for patients and […]

By Masako Hirota Quality really matters for us at Adragos. Here at the Japanese production facility in Kawagoe, about an hour outside Tokyo, we also have to meet the requirements of the Japanese market, which are a little different from […]

Munich / Courroux, November 25, 2024 – Adragos Pharma, a global pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Munich, Germany, has acquired Baccinex, a Swiss-based expert in aseptic fill-finish manufacturing. This acquisition significantly enhances Adragos’ sterile manufacturing capabilities […]